hg_96629.1

Basic information about the TSS

---

TSS ID: hg_96629.1 Species: human Chr: chr9		Start: 35732595 End: 35732643 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000486056.1 U88528 AK313635 AK299781 Distance: 0 GeneID: 10488 HGNC/MGI_ID: HGNC:2347 UniProt_ID: B2R947 B4DSK1

Gene_name: cAMP responsive element binding protein 3 Gene_symbol: CREB3 Gene_synonyms: LZIP Luman sLZIP Gene_source: HGNC:2347

TATA-Box annotation

---

Distance to TSS:	-47
Nearest PromoterID:	NM_006368
Entrez ID:	10488
Nearest Unigene:	Hs.522110
Nearest Refseq:	NM_006368
Nearest Ensembl:	ENSG00000107175
Gene Name:	cAMP responsive element binding protein 3
Gene Alias:	LUMAN|LZIP|sLZIP
Gene Description:	cAMP responsive element binding protein 3
Gene Type:	protein-coding
CpG%:	0.065
GC%:	0.651741
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CREB3 p2@CREB3 p3@CREB3 p4@CREB3 p5@CREB3
Sample		p1@CREB3	p2@CREB3	p3@CREB3	p4@CREB3	p5@CREB3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	6.82	4.68	1.95	1.56	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	6.88	5.66	1.42	1.82	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	6.94	4.82	1.74	1.74	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	5.82	6.03	1.46	0.83	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	6.97	6.52	2.02	1.35	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	5.62	6.20	1.94	0.58	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	12.20	16.34	2.40	1.31	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	10.90	12.84	2.66	1.21	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	8.55	11.75	1.92	0.85	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	11.01	28.98	5.22	1.74	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.11	31.93	3.64	1.21	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.16	31.30	2.03	2.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	9.67	2.26	1.13	0.81	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	11.73	4.96	1.20	1.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	5.71	3.51	1.32	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	10.06	1.51	0.75	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	7.21	5.90	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.01	3.37	2.95	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	6.40	2.13	1.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	11.58	3.61	1.65	0.90	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	10.56	3.88	1.87	0.40	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.88	8.46	1.04	1.04	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.95	4.78	1.81	0.52	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	8.25	5.58	1.21	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	7.74	6.45	1.55	1.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.98	6.01	2.53	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.89	6.04	2.75	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	11.32	11.32	1.89	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.01	8.56	0.65	0.48	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	9.23	8.87	3.08	0.90	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.84	12.14	0.63	1.05	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.96	12.70	0.98	0.39	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	7.17	8.44	1.06	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	13.53	13.03	2.97	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	14.40	11.03	1.87	1.12	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.01	11.11	1.15	1.34	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	11.04	16.96	1.84	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.28	12.09	1.81	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.64	15.67	1.35	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.64	16.80	1.68	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.70	13.65	1.88	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	12.15	16.40	1.17	0.88	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	13.29	18.35	1.27	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	9.44	18.88	1.40	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.23	17.87	1.61	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	11.63	20.71	2.09	0.70	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	9.36	21.59	0.72	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	12.82	19.37	1.19	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.57	20.11	1.91	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	12.54	23.86	1.01	0.20	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.68	30.74	1.02	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.23	41.36	1.78	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	167.91	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	7.45	34.78	0.71	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.94	29.82	1.33	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	12.58	76.34	3.36	0.00	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	10.56	55.57	2.76	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	9.40	37.60	0.97	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.35	35.97	0.96	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	17.92	62.24	1.57	0.31	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.76	35.25	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.22	37.57	1.12	0.00	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.94	82.80	5.57	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	11.55	73.05	2.04	0.34	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.55	32.82	0.65	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	10.65	42.60	0.35	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	226.30	0.00	0.00	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	355.39	15.79	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.80	40.95	0.98	0.49	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.45	36.69	0.99	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	12.20	45.97	2.35	1.41	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	10.27	36.76	1.66	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	7.42	26.29	0.31	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	9.17	25.68	1.53	0.61	0.61
Adipocyte - breast, donor1	11376-118A8	19.48	9.98	4.59	0.63	1.43
Adipocyte - breast, donor2	11327-117E4	13.80	6.58	2.73	0.32	1.60
Adipocyte - omental, donor1	11473-119C6	16.54	10.31	5.09	0.25	1.53
Adipocyte - omental, donor2	11474-119C7	22.42	16.44	2.24	0.00	3.74
Adipocyte - omental, donor3	11475-119C8	13.06	7.03	3.35	0.33	1.00
Adipocyte - perirenal, donor1	11476-119C9	16.59	7.66	2.55	0.64	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	7.70	3.30	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	16.26	8.58	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	15.47	2.95	2.61	0.87	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	16.04	3.52	2.74	0.59	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	9.27	3.60	1.03	1.03	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	7.25	6.69	2.23	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	9.40	4.70	4.11	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	14.72	3.70	0.97	0.56	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	9.04	3.87	1.61	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	10.13	3.20	0.53	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	6.68	3.34	2.23	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	12.06	3.33	3.33	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	8.04	4.52	2.01	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	10.14	7.53	2.95	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	7.61	1.83	0.91	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	28.07	24.53	5.75	0.66	4.86
Alveolar Epithelial Cells, donor2	11590-120G6	34.78	39.09	7.17	1.79	4.66
Alveolar Epithelial Cells, donor3	11671-122G6	17.97	10.78	3.59	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	17.09	2.34	3.42	0.90	1.80
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	1.67	5.02	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	20.54	6.78	3.49	0.62	0.62
Anulus Pulposus Cell, donor1	11248-116E6	16.13	2.63	2.75	0.46	0.23
Anulus Pulposus Cell, donor2	11463-119B5	16.41	2.45	2.69	0.73	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	14.38	13.03	4.94	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	13.89	17.37	3.47	0.00	2.60
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	10.70	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	14.05	13.45	3.59	0.60	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	15.18	16.44	5.06	0.00	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.22	17.16	2.64	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	16.89	10.72	1.95	0.32	2.27
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.02	15.05	4.85	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	6.53	11.88	5.34	0.00	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	15.82	14.31	4.90	1.51	2.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.79	18.87	1.45	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	11.28	2.51	0.00	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	16.31	21.58	5.11	0.33	1.32
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	15.01	10.92	4.09	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	14.33	14.93	2.11	0.45	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.54	12.86	3.21	0.54	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	17.19	15.68	3.40	0.57	1.70
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	10.69	16.04	2.67	0.00	2.41
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	9.75	14.63	2.93	0.98	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	17.42	15.76	2.49	0.17	1.82
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	24.01	1.20	2.40	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	17.70	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	15.27	17.32	3.95	0.34	1.37
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	12.58	8.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	17.96	13.11	3.88	0.00	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	20.11	18.59	1.90	0.00	1.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	7.27	4.85	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	14.25	23.94	1.14	0.57	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	13.68	15.39	2.78	0.21	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.65	16.52	2.58	0.77	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.14	13.14	1.88	0.00	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	16.72	14.47	2.89	0.00	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	19.26	16.41	5.71	2.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	12.87	16.38	7.02	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	13.85	19.57	3.61	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	20.20	21.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.22	17.80	2.03	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.01	17.06	3.06	0.25	2.29
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	20.97	20.97	2.54	0.64	3.81
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	14.67	14.67	3.45	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	14.82	13.76	2.12	0.42	1.69
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.89	16.24	2.32	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	12.28	13.23	0.94	0.00	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.60	14.41	3.22	0.00	1.53
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	13.90	4.63	0.00	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	27.46	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	15.22	20.15	2.36	0.00	2.36
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	7.82	26.47	3.01	0.00	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	15.31	16.77	3.64	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	16.78	19.31	3.45	0.00	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	17.85	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	19.83	21.10	5.34	0.25	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.55	19.20	3.51	0.21	1.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.55	19.28	3.06	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.73	21.99	3.35	0.00	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	15.30	15.30	4.21	0.00	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	12.21	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.97	26.03	4.98	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	15.62	21.98	2.38	0.79	2.38
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	13.45	20.72	2.91	0.00	1.82
Astrocyte - cerebellum, donor1	11500-119F6	21.12	5.90	5.28	2.21	0.98
Astrocyte - cerebellum, donor2	11580-120F5	24.30	5.31	5.65	1.20	1.54
Astrocyte - cerebellum, donor3	11661-122F5	15.94	5.87	2.10	2.52	1.68
Astrocyte - cerebral cortex, donor1	11235-116D2	24.05	6.62	2.79	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	16.18	5.18	1.94	1.46	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	19.84	10.74	2.68	1.64	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	4.70	2.29	4.36	0.34	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	5.26	3.63	3.88	0.25	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	4.21	2.16	3.07	0.46	0.46
Basophils, donor1	12241-129G9	8.63	2.09	7.85	0.52	0.52
Basophils, donor2	12242-129H1	6.49	2.53	4.69	1.80	0.00
Basophils, donor3	12243-129H2	6.17	1.62	3.67	0.29	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	9.27	1.94	0.86	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	17.83	6.86	3.20	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	18.20	9.41	2.51	0.00	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	27.24	8.53	3.33	0.62	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	27.40	5.07	3.91	0.92	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	8.10	1.98	1.26	1.26	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	2.99	0.00	2.58	0.00	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	5.12	0.23	3.96	0.00	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	10.87	0.32	5.76	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	9.02	1.13	1.13	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	4.64	2.23	2.60	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	5.05	2.20	2.63	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	11.89	1.42	0.57	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	10.61	0.00	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	7.89	2.63	0.66	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	5.64	3.47	0.58	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	2.72	2.72	1.21	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	4.03	2.37	1.90	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.85	9.54	0.17	0.00	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	3.04	4.97	0.55	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	5.70	6.69	0.74	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	3.72	3.52	0.78	0.00	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2.31	3.56	0.71	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	7.62	5.22	1.52	0.00	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.11	4.92	1.17	0.00	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2.11	4.75	1.06	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	9.98	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	5.65	6.25	1.64	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	3.19	6.39	0.60	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.66	9.99	0.62	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	3.66	7.32	0.69	0.00	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	3.39	8.60	0.68	0.00	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3.49	4.80	1.31	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.57	4.03	0.00	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	2.79	2.62	1.05	0.00	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	2.52	2.52	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.78	9.74	1.10	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3.17	7.40	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1.32	6.14	0.44	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1.92	2.27	0.87	0.00	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	3.72	2.60	0.37	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	5.39	6.68	2.16	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.09	7.78	1.64	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3.01	9.97	0.70	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	5.80	13.92	0.70	0.00	1.39
CD14+CD16+ Monocytes, donor1	11789-124B7	10.90	1.31	1.96	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	6.70	2.08	1.62	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	9.96	4.33	2.17	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	7.16	4.05	2.65	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	6.46	2.62	2.10	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	6.91	2.68	1.34	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	9.19	2.04	2.04	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	6.15	1.10	2.85	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	7.37	1.68	1.47	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	0.00	14.23	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	8.14	0.00	11.53	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	5.18	1.04	9.32	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	7.46	4.80	9.06	0.00	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	7.50	0.00	14.47	0.54	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	4.91	0.00	14.74	0.00	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	4.71	0.00	10.20	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	5.27	0.00	19.77	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	0.82	0.00	3.29	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	2.90	0.73	8.71	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	2.02	0.00	5.05	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	3.23	0.00	4.04	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	3.60	0.00	3.60	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	5.02	0.00	4.02	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	2.81	3.37	6.18	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	13.90	1.50	4.88	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	10.15	0.00	5.64	0.45	0.23
CD4+ T Cells, donor1	11225-116C1	1.79	0.71	10.35	0.71	0.00
CD4+ T Cells, donor2	11306-117C1	4.29	1.22	9.19	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	3.96	0.61	8.54	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	4.85	0.26	7.40	0.77	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	3.37	0.00	8.09	0.45	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	3.16	0.00	9.49	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1.90	0.00	10.90	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	5.62	0.00	13.34	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	9.89	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	5.64	0.29	8.38	0.43	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	4.07	0.51	5.25	0.68	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	3.87	0.32	4.84	0.81	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	4.93	0.00	10.31	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	5.94	0.00	14.67	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	3.96	0.44	11.00	1.32	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	6.32	0.42	3.79	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	6.03	0.21	5.61	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	5.68	0.00	8.02	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	3.26	0.00	8.70	1.09	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	2.68	0.54	12.33	1.07	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	0.00	7.17	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	6.68	0.00	8.53	0.37	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	6.07	0.00	8.01	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	5.04	0.21	9.04	0.42	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	3.54	0.00	12.13	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	8.67	0.00	16.46	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	3.49	0.00	7.84	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	9.40	0.49	16.33	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	8.31	0.00	24.93	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	13.96	0.00	12.56	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	9.14	0.28	19.66	1.38	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	11.04	0.49	19.88	1.96	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	6.16	0.00	12.32	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	10.03	1.43	13.97	1.79	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	8.31	1.38	18.00	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	3.93	0.33	9.17	2.29	0.00
CD8+ T Cells, donor2	11307-117C2	4.51	1.13	9.01	1.13	0.75
CD8+ T Cells, donor3	11383-118B6	4.80	0.00	8.08	0.25	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.51	28.44	1.15	1.15	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	1.44	20.13	0.72	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	2.19	19.15	2.74	0.27	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.90	28.52	0.30	0.30	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	3.36	26.64	2.64	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.78	25.24	1.36	0.45	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.00	27.38	2.17	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.42	26.58	2.11	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	3.75	22.98	2.11	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	2.42	23.55	1.51	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	4.07	22.37	1.74	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2.40	24.78	0.80	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	5.25	26.70	1.75	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	6.38	22.32	0.91	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	3.73	35.06	0.75	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.04	34.57	1.80	1.08	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.89	29.92	1.73	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	3.06	26.16	1.65	0.71	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	4.75	28.84	2.22	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	3.38	24.61	0.92	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	3.21	18.27	0.96	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	5.74	24.86	1.91	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	4.34	21.28	2.76	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	15.13	1.51	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	4.01	41.75	1.61	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	1.40	39.87	1.40	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	0.00	41.07	3.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	7.31	3.66	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	15.32	7.91	1.48	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	17.99	8.00	2.74	0.32	1.89
Chondrocyte - de diff, donor1	11261-116G1	12.83	9.01	2.08	1.04	2.77
Chondrocyte - de diff, donor2	11338-117F6	18.48	13.86	5.33	1.07	2.49
Chondrocyte - de diff, donor3	11410-118E6	13.31	5.80	3.07	1.59	1.93
Chondrocyte - re diff, donor2	11339-117F7	18.80	17.91	1.79	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	20.22	15.37	2.43	1.21	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	15.38	6.43	2.18	1.61	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	19.03	5.99	7.05	0.86	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	17.17	6.55	3.45	0.88	1.42
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	14.86	4.03	6.88	2.75	0.28
Corneal Epithelial Cells, donor1	11526-119I5	15.81	1.98	1.76	0.88	0.22
Corneal Epithelial Cells, donor2	11606-120I4	15.93	1.14	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	14.83	1.28	3.58	0.77	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	14.69	9.58	1.32	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	20.50	12.62	2.84	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	3.45	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	12.31	7.45	0.97	0.00	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	7.52	0.00	9.22	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	5.88	0.00	7.83	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	5.32	0.00	8.23	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	18.18	6.67	2.17	1.67	2.17
Endothelial Cells - Aortic, donor1	11263-116G3	17.02	8.21	2.93	0.59	5.28
Endothelial Cells - Aortic, donor2	11340-117F8	16.69	7.64	2.83	0.57	2.83
Endothelial Cells - Aortic, donor3	11412-118E8	14.94	15.73	3.15	1.18	3.93
Endothelial Cells - Artery, donor1	11264-116G4	14.83	14.54	3.20	0.00	3.20
Endothelial Cells - Artery, donor2	11341-117F9	12.23	8.23	1.41	0.71	2.12
Endothelial Cells - Artery, donor3	11413-118E9	17.00	9.82	2.98	0.18	2.10
Endothelial Cells - Lymphatic, donor1	11236-116D3	11.75	3.99	1.55	0.66	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	12.47	4.87	0.91	0.91	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	6.77	4.79	0.85	1.69	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	18.42	20.21	4.46	1.19	2.08
Endothelial Cells - Microvascular, donor2	11342-117G1	18.74	20.31	4.69	0.52	4.69
Endothelial Cells - Microvascular, donor3	11414-118F1	10.63	9.50	1.42	1.84	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	12.00	6.80	1.20	0.40	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	19.39	14.15	2.62	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	13.29	4.97	2.11	0.75	1.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	11.51	3.69	3.04	0.65	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	14.17	4.52	1.59	0.37	0.61
Endothelial Cells - Vein, donor1	11267-116G7	10.24	3.41	1.14	2.28	2.28
Endothelial Cells - Vein, donor2	11344-117G3	16.76	6.99	4.19	3.49	1.40
Endothelial Cells - Vein, donor3	11416-118F3	15.86	5.02	2.20	1.41	0.79
Eosinophils, donor1	12244-129H3	0.00	15.25	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	19.80	49.51	21.45	1.65	0.00
Eosinophils, donor3	12246-129H5	3.57	42.80	14.27	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	16.13	3.42	1.71	0.24	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	16.42	13.96	3.69	0.82	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	15.55	11.82	4.27	0.44	1.42
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	18.20	3.68	4.01	0.76	1.19
Fibroblast - Aortic Adventitial, donor1	11245-116E3	17.71	11.28	3.03	0.49	1.46
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	15.83	13.92	3.00	0.68	2.46
Fibroblast - Aortic Adventitial, donor2	11326-117E3	14.03	12.55	3.16	0.42	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.01	10.28	2.11	0.00	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	18.60	7.31	1.99	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	19.96	8.17	6.35	0.45	1.81
Fibroblast - Cardiac, donor2	11345-117G4	20.46	30.32	5.31	0.00	2.27
Fibroblast - Cardiac, donor3	11417-118F4	26.34	19.71	4.26	0.63	3.00
Fibroblast - Cardiac, donor4	11452-119A3	13.64	2.12	1.21	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	13.45	8.38	2.16	0.63	0.38
Fibroblast - Cardiac, donor6	11460-119B2	12.13	5.76	2.12	0.76	1.67
Fibroblast - Choroid Plexus, donor1	11492-119E7	17.95	3.35	2.95	1.47	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.63	3.02	2.16	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	8.79	4.39	5.86	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	29.52	7.15	4.61	1.61	1.38
Fibroblast - Conjunctival, donor3	11692-122I9	12.21	2.04	1.53	0.68	0.51
Fibroblast - Dermal, donor1	11269-116G9	11.74	4.46	1.64	0.94	0.23
Fibroblast - Dermal, donor2	11346-117G5	23.58	5.66	4.72	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	13.18	5.56	1.81	0.24	0.24
Fibroblast - Dermal, donor4	11450-119A1	13.57	3.73	2.49	0.34	0.23
Fibroblast - Dermal, donor5	11454-119A5	12.91	1.74	2.09	1.57	0.17
Fibroblast - Dermal, donor6	11458-119A9	13.64	4.06	2.92	0.81	0.00
Fibroblast - Gingival, donor1	11237-116D4	21.03	3.96	2.50	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	19.13	11.53	3.67	0.26	3.14
Fibroblast - Gingival, donor2	11318-117D4	17.26	3.95	2.50	1.05	0.53
Fibroblast - Gingival, donor3	11394-118C8	14.79	1.93	2.13	0.48	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	22.86	8.31	2.08	2.08	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	20.44	10.40	2.29	0.70	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	19.18	8.73	3.90	1.09	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	19.88	5.41	2.70	0.54	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	12.35	10.23	2.47	0.00	2.47
Fibroblast - Gingival, donor7 (control)	11924-125H7	16.09	10.97	3.07	0.29	1.46
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	15.68	7.64	4.36	0.55	2.05
Fibroblast - Gingival, donor8 (control)	11926-125H9	18.32	10.31	2.63	0.66	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	18.49	4.55	4.11	1.32	0.59
Fibroblast - Lung, donor1	11270-116H1	10.87	4.08	2.72	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	1.49	1.49	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	16.46	2.53	2.53	2.11	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	30.82	26.66	6.66	1.67	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	18.18	9.79	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	18.47	22.11	2.24	0.84	0.84
Fibroblast - Mammary, donor1	11540-120B1	27.61	10.15	2.44	0.41	1.62
Fibroblast - Mammary, donor2	11620-122A9	23.97	15.98	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	17.87	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	16.49	2.13	3.49	0.78	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	14.41	1.21	1.97	2.12	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	23.87	3.98	1.84	0.00	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	18.70	7.25	3.82	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	20.52	10.26	4.32	0.81	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.51	6.73	1.51	0.12	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	22.33	14.04	3.76	0.77	3.21
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	37.39	21.74	3.45	2.03	2.44
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	21.38	8.02	3.34	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.58	4.74	3.16	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	10.12	10.91	2.98	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	19.72	6.39	2.31	0.36	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	17.74	12.81	3.55	0.99	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	11.13	7.82	4.21	0.90	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	20.83	9.50	2.59	1.08	1.30
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	12.65	9.87	2.28	0.76	1.52
Fibroblast - skin normal, donor1	11553-120C5	27.73	14.27	4.10	0.66	1.64
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	12.83	12.43	2.61	0.40	1.00
Fibroblast - skin normal, donor2	11561-120D4	25.72	14.77	5.93	1.11	2.71
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	15.72	9.67	2.12	0.91	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	15.58	9.03	3.31	1.08	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	23.76	7.52	2.91	0.51	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	11.17	12.15	3.94	0.99	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	31.32	13.74	6.60	0.85	2.88
Fibroblast - skin walker warburg, donor1	11554-120C6	26.31	13.33	4.55	0.34	2.19
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	31.05	16.00	5.02	0.47	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	66.48	22.16	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	2.61	0.00	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	18.20	15.08	2.77	0.35	1.56
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	18.48	9.89	3.64	1.30	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	17.37	8.94	2.81	0.26	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	12.25	4.59	0.00	6.12	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	5.74	1.28	3.19	5.74	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	10.84	2.57	1.14	1.43	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	16.27	3.58	2.21	5.24	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	12.33	3.20	2.05	3.65	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	10.10	3.37	1.59	2.97	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	12.69	2.64	0.79	5.29	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	13.05	4.57	1.96	2.61	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	12.82	5.31	3.54	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	8.76	2.97	1.13	3.11	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	8.50	5.05	1.72	2.22	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	6.98	1.34	2.42	1.88	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	9.29	6.44	1.86	2.73	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	9.83	7.48	1.38	1.52	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	6.71	3.05	1.22	1.02	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	8.21	6.39	1.83	1.83	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	13.58	4.86	1.12	2.37	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	11.15	5.68	0.66	1.97	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	11.52	5.32	2.07	1.77	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	9.86	3.34	1.91	1.75	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	10.72	2.46	1.34	2.46	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	9.48	2.02	2.62	2.02	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	11.37	4.58	1.53	2.71	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	10.20	5.94	1.33	1.33	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	9.37	2.08	1.98	2.50	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	8.37	2.39	2.22	3.42	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	10.73	2.55	2.21	2.55	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	12.65	5.91	2.33	1.33	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	12.86	5.10	2.04	1.84	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	10.93	3.09	1.65	4.33	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	11.18	2.77	1.84	2.31	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	10.51	3.50	1.00	2.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	9.70	0.88	1.76	3.09	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	12.18	3.57	2.21	1.97	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	11.83	4.05	1.62	2.43	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	10.26	5.13	2.25	2.57	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	9.00	1.90	2.46	2.18	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	8.70	0.79	1.58	1.74	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	9.73	2.43	2.74	4.87	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.14	2.51	1.57	1.46	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	9.00	1.10	1.98	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	10.10	2.81	2.24	1.68	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	12.04	3.70	1.39	1.20	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	7.49	1.60	1.60	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	9.79	3.98	1.22	0.92	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	11.27	4.15	1.17	1.42	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	12.74	1.08	0.81	1.63	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	10.88	5.53	1.84	0.92	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	11.40	1.32	2.19	1.54	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	4.96	0.00	0.99	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	12.14	6.99	2.37	0.92	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	16.14	4.64	3.83	0.81	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	12.71	0.51	1.52	1.52	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	9.16	4.38	1.59	1.79	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	8.63	2.31	1.69	2.31	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	6.55	3.48	0.61	4.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	14.71	4.69	2.19	2.82	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	11.87	4.80	1.41	1.98	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	5.07	1.38	1.84	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	9.90	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	16.25	5.42	1.16	3.48	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	9.63	3.21	4.81	4.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	15.65	8.69	0.00	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	7.16	6.18	2.28	1.95	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	11.53	4.12	1.65	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	6.66	3.33	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	11.75	3.64	0.28	3.08	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	9.81	3.92	1.63	2.94	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	8.39	0.84	2.52	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	10.50	3.50	2.86	3.82	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	11.21	2.04	2.38	5.43	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	6.26	8.35	8.35	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	10.31	0.57	1.72	2.86	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	12.43	2.66	2.66	2.37	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	16.94	3.39	1.69	8.47	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	17.40	7.87	3.31	2.90	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.28	5.52	2.99	2.53	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.84	3.84	0.38	1.54	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	13.04	5.54	4.24	2.61	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	14.05	2.68	2.68	3.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	12.33	3.08	3.47	5.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	15.41	8.22	5.48	3.77	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	0.00	2.48	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	10.38	3.30	3.77	4.25	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	12.67	5.43	5.43	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	10.68	4.07	4.07	4.58	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	12.76	2.39	3.19	5.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	21.71	3.95	2.47	4.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	23.61	5.90	1.18	5.90	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	9.92	3.50	4.67	2.92	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	22.38	6.14	3.51	4.83	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	17.80	4.24	5.09	2.54	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	12.54	5.37	4.78	3.58	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	17.47	3.88	3.88	1.46	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	28.53	35.38	6.85	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	18.71	9.98	3.33	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	48.35	39.36	6.75	0.00	5.62
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5.71	10.47	2.54	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	14.20	9.19	0.84	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	12.18	5.92	2.79	0.93	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	9.96	3.54	4.05	1.01	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	8.65	3.64	2.05	1.14	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	12.90	5.90	3.94	0.33	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	11.39	6.23	5.16	0.64	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	9.69	3.23	1.72	0.43	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	12.33	5.36	2.62	0.37	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	8.23	4.97	2.23	0.69	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.73	4.49	1.92	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	12.87	5.60	2.24	0.56	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	18.61	9.52	1.30	0.87	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	5.29	5.29	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	27.16	11.99	4.94	0.35	2.47
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	20.34	6.54	1.45	0.00	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	20.63	6.99	4.55	0.17	1.75
Hepatocyte, donor1	11523-119I2	4.84	3.63	2.42	2.42	0.00
Hepatocyte, donor2	11603-120I1	17.24	9.70	3.23	2.15	2.15
Hepatocyte, donor3	11684-122I1	6.14	3.68	0.61	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	7.18	0.65	2.61	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	15.03	11.19	3.15	2.80	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	16.60	5.90	2.88	0.55	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	0.00	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	8.31	5.54	0.00	2.77	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	0.00	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	11.87	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	0.00	2.56	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	4.87	0.00	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	3.33	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	3.63	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	11.91	5.29	1.32	3.97	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	9.98	0.00	1.11	2.22	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	5.24	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.93	2.52	3.15	3.78	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	9.28	1.55	0.00	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	10.34	3.88	1.29	1.94	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	0.00	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	13.85	2.44	3.26	0.81	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	8.40	3.36	0.84	0.84	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.04	4.02	4.82	1.61	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	7.39	3.69	1.85	0.92	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	7.55	1.42	3.30	2.36	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	8.16	1.81	4.53	2.72	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	14.74	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	8.61	0.00	3.23	3.23	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	1.27	3.81	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	32.86	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	8.93	1.28	3.19	0.64	3.83
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	0.00	3.65	5.47	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.00	4.28	0.71	4.28	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.48	2.16	0.62	1.85	2.16
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	3.51	3.51	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	6.29	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	8.34	3.48	2.09	3.48	4.17
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	2.21	2.21	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	0.00	3.24	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	9.59	4.36	0.87	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	4.50	4.50	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	3.48	0.00	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	1.07	1.07	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	2.77	1.39	4.16	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	0.00	0.92	4.60	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	7.40	3.17	3.17	1.06	2.11
Keratinocyte - epidermal, donor1	11272-116H3	8.49	3.67	2.61	0.65	1.06
Keratinocyte - epidermal, donor2	11349-117G8	16.40	6.44	1.76	1.76	1.17
Keratinocyte - epidermal, donor3	11421-118F8	10.32	1.61	2.18	0.28	0.09
Keratinocyte - oral, donor1	11251-116E9	12.49	2.27	2.27	0.91	0.34
Keratocytes, donor1	11527-119I6	39.88	10.31	2.75	0.34	0.00
Keratocytes, donor2	11607-120I5	23.44	5.86	4.69	0.00	1.17
Keratocytes, donor3	11688-122I5	16.20	1.58	2.37	0.40	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	10.99	13.19	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	8.63	4.31	1.08	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	17.42	4.15	1.73	0.92	0.12
Lens Epithelial Cells, donor3	11690-122I7	26.44	10.80	3.63	0.30	1.82
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.62	12.81	2.37	1.30	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.14	8.37	1.12	0.28	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.34	9.76	0.94	1.10	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	9.14	11.83	2.15	0.54	3.76
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.41	8.51	0.63	0.32	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.33	8.95	2.48	1.19	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.16	5.75	2.46	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.31	11.12	1.77	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.18	10.27	1.27	0.84	0.99
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	6.33	7.52	0.79	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	3.88	5.62	0.58	0.58	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.85	11.85	2.04	0.93	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	4.18	10.45	1.39	0.35	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	4.29	8.83	0.95	0.48	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.32	9.48	2.20	0.55	1.37
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.24	10.16	0.62	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.43	9.35	0.62	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	7.50	11.71	2.38	1.65	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	6.25	10.20	1.32	0.66	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.98	11.42	2.05	0.00	2.34
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.22	12.20	1.00	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	4.36	9.70	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	5.92	6.46	0.81	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.69	9.69	1.67	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.74	11.41	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	4.61	7.12	0.84	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.62	7.52	1.95	1.35	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.88	11.01	3.44	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	4.89	7.90	0.94	1.32	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.69	8.80	2.01	0.85	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	3.88	11.15	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3.64	8.60	0.66	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.92	9.66	1.98	0.99	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	12.96	12.59	3.33	1.11	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.46	10.38	0.49	0.49	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.56	9.49	0.82	0.41	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.04	7.72	0.64	0.32	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	3.04	8.22	2.43	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	6.58	9.24	1.26	0.98	1.12
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.60	11.73	1.07	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.88	12.60	0.48	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	9.34	11.98	2.65	0.93	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	10.03	11.82	1.43	1.43	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	3.59	10.13	0.65	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.95	12.95	0.94	0.94	1.41
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.50	13.86	1.49	1.73	1.86
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.84	7.17	0.51	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.95	8.95	1.49	1.19	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	27.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	9.21	3.07	3.07	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	8.16	1.48	1.48	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.89	0.85	2.96	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.25	0.00	2.81	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	15.88	2.80	3.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.70	1.03	6.18	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	17.84	3.57	5.95	3.57	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	16.06	3.62	3.62	1.36	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.40	4.36	3.20	1.74	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	13.96	0.90	3.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15.58	3.39	3.25	0.54	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.73	3.08	2.05	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	14.82	2.12	3.88	1.41	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.00	2.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	9.68	1.53	4.58	1.53	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	12.01	1.60	1.87	0.53	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.79	1.51	4.91	0.76	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	6.75	2.45	4.29	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.05	4.89	1.63	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	14.99	2.29	2.92	1.25	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	9.53	2.24	2.52	1.12	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	16.49	1.03	3.09	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	15.97	2.90	3.48	1.45	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	7.47	1.79	3.59	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	13.28	0.55	3.32	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	13.43	1.41	4.24	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	9.22	2.21	2.58	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	23.03	2.30	4.61	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	15.35	2.30	3.45	1.54	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	10.76	2.26	2.83	1.13	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13.95	1.64	5.74	0.00	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.10	1.81	6.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	15.08	1.44	4.31	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	15.68	2.99	2.24	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	15.61	2.60	3.34	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	13.78	2.58	3.88	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	10.28	2.57	0.86	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	14.33	2.67	4.00	2.33	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	13.27	1.81	2.41	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.93	1.42	2.13	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	16.50	2.75	3.44	1.37	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	13.42	3.22	3.76	1.61	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	11.45	3.37	3.37	1.35	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	14.45	2.96	2.22	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	18.61	9.30	2.33	2.33	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	4.23	2.12	4.23	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	13.20	2.00	2.40	0.80	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.18	2.18	2.91	2.18	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	23.76	3.07	2.30	2.30	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	8.39	3.95	3.95	1.97	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	10.35	5.65	1.88	1.88	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	20.11	3.02	5.53	3.02	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.81	1.35	1.35	0.45	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	3.44	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	17.81	3.12	3.56	2.67	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.21	2.35	1.96	0.78	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	14.51	1.98	1.98	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	18.16	2.59	2.08	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	12.25	2.19	2.63	1.31	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	13.98	2.80	4.47	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	15.02	2.65	4.42	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	16.97	2.31	1.93	0.39	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	10.13	3.54	6.58	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	15.86	2.88	3.36	4.33	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	19.88	4.37	3.98	1.59	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	8.51	2.43	1.82	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	10.38	2.77	1.38	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	13.30	2.28	3.42	0.76	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	15.49	4.13	3.10	1.55	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	18.74	3.63	4.23	1.21	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	15.21	2.85	1.90	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	8.00	5.33	2.13	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	8.05	3.45	2.87	0.57	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	14.91	5.14	2.06	1.54	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.27	4.95	0.71	2.83	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.92	5.11	3.40	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	12.06	4.16	2.08	0.83	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.05	3.13	2.35	1.57	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	12.94	4.59	2.09	1.25	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	23.23	6.04	2.32	1.39	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10.04	4.01	1.34	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	12.30	4.81	2.14	1.07	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	17.78	5.25	1.21	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.03	12.85	3.67	0.00	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	12.45	5.33	5.33	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	25.07	4.56	5.70	0.57	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	14.57	5.37	2.30	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	13.68	4.38	5.47	1.09	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	25.84	8.91	3.12	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	19.24	7.02	3.12	0.52	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.91	5.97	2.65	0.66	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	6.24	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	8.66	2.51	1.14	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	11.38	8.44	1.47	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	10.22	5.90	1.31	0.13	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	24.43	19.12	6.90	1.06	3.72
Mallassez-derived cells, donor2	11929-125I3	18.22	17.27	5.86	1.11	3.49
Mallassez-derived cells, donor3	11930-125I4	15.57	12.37	4.03	1.67	1.39
Mammary Epithelial Cell, donor1	11273-116H4	22.22	10.36	3.89	0.30	0.50
Mammary Epithelial Cell, donor2	11350-117G9	13.03	10.42	4.34	0.58	1.45
Mammary Epithelial Cell, donor3	11422-118F9	21.20	4.49	1.75	0.75	1.25
Mast cell - stimulated, donor1	11487-119E2	13.56	7.46	4.07	0.00	2.71
Mast cell, donor1	11563-120D6	7.68	1.62	4.76	0.22	0.54
Mast cell, donor2	11565-120D8	14.56	27.04	6.24	0.30	1.49
Mast cell, donor3	11566-120D9	13.06	17.56	7.88	0.23	0.00
Mast cell, donor4	11567-120E1	13.12	25.53	8.33	0.18	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	7.98	4.44	6.43	0.11	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	4.67	2.92	4.09	0.00	1.75
Mast cell, expanded, donor5	11939-126A4	8.37	0.34	5.39	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	4.35	0.50	4.18	0.50	0.33
Melanocyte - dark, donor1	11502-119F8	9.55	7.06	1.39	0.70	1.49
Melanocyte - dark, donor2	11582-120F7	9.00	5.19	3.11	0.35	1.38
Melanocyte - dark, donor3	11663-122F7	16.01	2.46	2.17	0.87	0.29
Melanocyte - light, donor1	11274-116H5	13.87	2.35	2.12	0.24	0.24
Melanocyte - light, donor2	11351-117H1	14.33	3.41	2.73	0.68	0.00
Melanocyte - light, donor3	11423-118G1	16.48	2.60	4.34	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	12.60	1.67	3.44	0.83	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	17.48	2.96	4.30	0.81	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	8.84	1.07	1.34	1.61	0.00
Meningeal Cells, donor1	11493-119E8	17.74	4.34	3.23	1.74	0.87
Meningeal Cells, donor2	11573-120E7	11.44	2.20	1.76	1.32	2.20
Meningeal Cells, donor3	11654-122E7	12.55	3.83	2.85	1.39	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	23.10	7.41	3.14	0.86	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	18.01	19.12	3.72	0.10	1.91
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	2.63	0.00	0.00	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	22.24	9.16	5.23	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	18.66	8.61	4.31	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	19.69	16.09	2.12	0.64	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	23.12	11.56	2.51	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	26.59	5.49	4.40	0.88	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	27.03	7.31	5.11	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	25.37	9.00	2.66	0.82	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	18.01	5.54	2.49	0.69	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	20.82	12.27	1.86	1.12	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	15.66	6.45	2.50	0.92	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	19.29	3.56	1.48	0.00	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	19.85	8.33	3.20	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	27.65	11.70	3.19	2.48	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	16.57	5.94	2.50	1.56	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	26.85	4.35	2.90	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	17.77	11.14	5.04	0.53	4.77
Mesothelial Cells, donor2	12156-128G5	18.52	14.51	6.01	0.00	5.00
Mesothelial Cells, donor3	11402-118D7	11.92	10.41	3.76	0.43	2.38
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	14.85	6.75	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	13.79	6.40	2.71	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.24	6.48	2.06	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.33	5.27	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.96	5.60	2.49	0.00	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	4.63	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	11.26	8.51	2.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	10.24	9.31	0.47	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	10.57	4.88	1.42	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.90	7.13	1.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	8.85	5.31	2.65	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.50	11.02	2.66	0.00	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	15.79	10.53	3.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.43	8.91	2.12	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	7.37	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	6.26	7.15	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	11.74	5.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.29	10.29	1.51	0.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.84	8.79	0.95	0.00	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	23.77	2.76	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	9.90	20.26	1.38	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.84	10.52	1.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.95	11.41	1.63	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.23	14.16	1.07	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.67	19.12	0.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.69	19.71	1.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.56	11.66	2.53	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	19.88	1.66	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6.52	17.67	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.29	17.06	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	21.81	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	12.01	34.60	2.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	12.01	17.21	1.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	19.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	17.52	27.03	2.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	53.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	6.12	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.88	26.28	1.75	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	26.49	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.97	18.57	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.92	28.51	1.24	0.50	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	16.70	2.09	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	26.52	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	14.02	20.85	3.42	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.38	14.44	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9.59	15.62	0.36	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	9.54	23.85	3.09	0.28	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	11.64	22.03	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.99	12.82	0.00	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.46	18.40	1.81	0.30	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.93	20.03	1.67	0.00	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	4.62	15.70	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	13.66	22.76	1.14	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7.88	17.69	1.66	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	8.81	19.44	3.37	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.01	15.44	1.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	20.96	2.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.41	13.88	1.33	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	10.48	15.57	1.50	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.20	15.11	0.71	0.42	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	10.19	22.93	0.96	0.00	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	8.85	18.35	2.21	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.96	18.20	0.76	0.38	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	7.95	18.47	0.57	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	9.59	22.61	0.98	0.25	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.87	10.43	0.65	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.64	18.82	1.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	8.07	17.30	2.31	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	6.18	12.36	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	11.61	18.46	1.79	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	5.26	2.30	1.31	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	4.21	1.05	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	8.11	2.77	0.79	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	9.31	2.79	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	6.76	1.13	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	7.99	4.79	1.33	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	9.61	4.30	1.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.16	2.95	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	9.16	1.83	0.37	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	3.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.74	3.74	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	7.07	3.03	3.03	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.01	4.22	0.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	8.17	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	4.45	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	4.05	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	4.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	28.55	5.71	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	13.05	3.26	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	19.01	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	20.90	17.67	4.31	0.22	1.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	14.11	2.61	2.61	0.52	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.67	0.67	0.67	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	11.27	4.59	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	21.68	7.04	2.09	0.38	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	12.77	4.79	1.60	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	5.44	3.40	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	22.05	11.03	11.03	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.35	0.84	1.26	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	11.62	5.35	1.16	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	6.76	1.35	0.54	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	6.94	4.20	1.89	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	0.00	11.13	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.45	3.97	1.99	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	9.20	5.95	1.62	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	8.84	5.21	1.36	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.21	3.27	0.65	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	7.29	5.10	2.19	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.83	3.18	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	3.00	4.80	0.00	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	15.75	9.19	1.97	0.66	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.39	4.72	0.65	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	6.70	2.82	1.41	0.35	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	3.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	6.90	5.98	1.84	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.00	6.75	1.29	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	24.14	16.55	3.45	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	22.76	15.17	7.59	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	8.24	4.23	0.67	0.67	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	6.77	5.93	0.42	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	7.60	5.70	1.19	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	12.88	6.87	2.15	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6.66	8.66	1.00	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	8.12	3.61	0.00	0.00	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.33	5.95	0.79	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	7.43	2.79	2.79	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	19.68	8.70	1.51	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	7.82	4.56	0.33	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	5.23	1.74	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	7.69	4.52	1.81	0.00	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	5.29	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.31	4.65	1.99	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	4.96	6.94	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.21	4.21	0.77	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	17.84	4.84	2.72	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	11.05	5.30	1.55	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.07	4.07	0.00	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	20.44	15.33	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.93	6.71	0.61	0.61	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.44	5.67	1.26	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	7.87	1.82	0.91	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.12	4.75	3.16	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	14.74	9.07	4.53	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	5.06	10.12	0.00	0.00
Myoblast, donor1	11241-116D8	29.57	29.69	6.09	0.25	2.73
Myoblast, donor2	11322-117D8	21.10	8.44	2.49	0.58	0.19
Myoblast, donor3	11398-118D3	19.51	11.27	2.19	0.17	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	6.28	0.00	4.23	1.61	0.15
Natural Killer Cells, donor1	11230-116C6	3.69	1.54	10.15	2.15	0.31
Natural Killer Cells, donor2	11311-117C6	2.71	1.21	7.24	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	3.87	0.92	9.75	0.37	0.00
Neural stem cells, donor1	11275-116H6	14.15	5.81	1.45	1.45	0.00
Neural stem cells, donor2	11352-117H2	15.41	3.85	7.70	0.00	0.00
Neurons, donor1	11494-119E9	30.72	6.83	5.69	2.28	0.00
Neurons, donor2	11574-120E8	19.59	3.08	9.03	1.76	0.22
Neurons, donor3	11655-122E8	14.80	4.93	4.93	1.64	0.00
Neutrophils, donor1	11233-116C9	12.06	13.92	11.14	0.00	1.86
Neutrophils, donor2	11314-117C9	2.90	11.60	8.70	0.00	0.00
Neutrophils, donor3	11390-118C4	11.61	12.83	12.83	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	11.16	1.54	2.14	1.07	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	6.19	0.98	1.95	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	16.24	3.81	2.21	0.60	0.60
Olfactory epithelial cells, donor1	11933-125I7	9.77	8.26	0.96	0.14	0.96
Olfactory epithelial cells, donor2	11934-125I8	13.90	8.54	3.33	0.43	2.03
Olfactory epithelial cells, donor3	11935-125I9	12.94	8.06	2.27	0.23	1.14
Olfactory epithelial cells, donor4	11936-126A1	17.63	9.45	2.24	0.10	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	24.07	10.23	4.81	0.60	2.41
Osteoblast - differentiated, donor1	11276-116H7	19.36	8.30	3.19	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	20.58	5.72	6.86	1.14	2.29
Osteoblast - differentiated, donor3	11425-118G3	14.28	3.72	5.59	0.00	0.62
Osteoblast, donor1	11277-116H8	47.49	18.76	8.79	0.78	2.35
Osteoblast, donor2	11354-117H4	20.37	9.83	7.73	4.21	0.00
Osteoblast, donor3	11426-118G4	46.21	20.79	5.87	0.71	3.02
Pancreatic stromal cells, donor1	11249-116E7	22.58	10.87	3.54	0.67	1.35
Pericytes, donor1	11491-119E6	19.36	2.23	2.89	0.56	0.22
Pericytes, donor2	11571-120E5	15.17	1.81	4.30	1.36	0.00
Pericytes, donor3	11652-122E5	29.70	7.53	5.49	0.81	3.26
Perineurial Cells, donor1	11499-119F5	19.55	2.94	2.37	0.90	0.57
Perineurial Cells, donor2	11579-120F4	15.73	6.81	2.30	0.46	2.12
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	5.10	1.91	5.42	0.96	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	3.43	3.43	5.14	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	3.62	1.29	4.53	0.26	0.13
Placental Epithelial Cells, donor1	11278-116H9	41.14	13.39	13.15	1.67	3.35
Placental Epithelial Cells, donor2	11355-117H5	25.50	4.44	8.87	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	21.20	1.18	3.34	0.59	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	17.40	10.76	6.33	0.32	1.58
Preadipocyte - breast, donor1	11467-119B9	12.38	7.32	3.94	0.56	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	12.53	10.44	1.44	0.26	1.44
Preadipocyte - breast, donor2	11328-117E5	21.39	7.88	4.05	0.68	2.70
Preadipocyte - omental, donor1	11468-119C1	18.22	6.07	3.52	0.32	1.39
Preadipocyte - omental, donor2	11329-117E6	18.77	10.48	2.62	0.44	2.62
Preadipocyte - omental, donor3	11403-118D8	20.48	10.03	6.73	0.29	2.44
Preadipocyte - perirenal, donor1	11469-119C2	25.59	7.87	3.94	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	53.13	37.16	5.84	0.61	2.15
Preadipocyte - subcutaneous, donor2	11356-117H6	20.19	12.93	3.90	1.24	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	26.73	17.71	2.55	0.68	1.36
Preadipocyte - visceral, donor1	11280-116I2	15.93	8.85	2.79	0.47	0.75
Preadipocyte - visceral, donor2	11357-117H7	14.73	11.04	3.22	0.46	1.84
Preadipocyte - visceral, donor3	11429-118G7	18.18	9.61	3.03	0.63	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	10.86	10.71	1.81	0.91	0.60
Prostate Epithelial Cells, donor2	11331-117E8	18.55	8.12	4.74	0.00	1.76
Prostate Epithelial Cells, donor3	11404-118D9	7.72	0.86	1.71	0.67	0.43
Prostate Stromal Cells, donor1	11254-116F3	22.78	13.10	3.64	0.91	2.39
Prostate Stromal Cells, donor2	11332-117E9	20.98	20.98	5.20	0.72	1.43
Prostate Stromal Cells, donor3	11405-118E1	17.62	17.21	3.44	1.04	1.67
Renal Cortical Epithelial Cells, donor1	11516-119H4	14.60	9.49	3.28	1.46	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	10.40	4.71	1.80	1.04	0.21
Renal Epithelial Cells, donor1	11517-119H5	19.78	7.61	8.12	1.52	0.51
Renal Epithelial Cells, donor2	11597-120H4	24.90	7.11	4.27	2.13	0.00
Renal Epithelial Cells, donor3	11678-122H4	11.12	6.35	1.69	1.59	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.98	6.81	0.68	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	17.65	6.06	2.29	0.81	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	13.76	6.44	3.11	0.67	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	10.65	11.31	2.66	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	28.61	12.77	3.96	0.44	1.10
Renal Mesangial Cells, donor2	11598-120H5	23.20	10.03	3.13	2.51	0.63
Renal Mesangial Cells, donor3	11679-122H5	19.70	14.43	1.94	1.11	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	20.67	12.08	1.88	0.81	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.07	11.81	4.22	1.69	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	16.20	6.36	2.12	1.54	1.35
Retinal Pigment Epithelial Cells, donor0	11215-116A9	15.82	1.81	2.85	1.04	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	12.79	1.71	1.14	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	5.15	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	6.02	0.75	1.00	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	10.69	2.54	2.67	1.34	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	2.68	0.89	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1.65	1.10	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	5.22	1.74	1.74	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	8.06	1.82	0.78	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	6.95	3.08	1.09	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	8.14	3.68	1.00	0.78	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	10.30	2.60	0.74	0.74	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	9.09	1.63	1.28	0.47	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	8.55	3.47	1.16	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	6.16	1.37	1.10	0.96	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	7.71	1.51	1.66	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	13.08	2.33	1.08	0.72	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	5.16	2.58	1.43	0.57	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	8.69	2.15	1.50	0.64	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	10.62	1.99	1.55	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	4.78	2.68	1.15	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	6.89	1.58	0.93	0.37	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	7.89	2.07	0.56	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	6.77	2.65	1.06	0.53	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	8.86	1.95	1.95	0.97	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	8.21	2.86	1.15	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	6.83	2.99	0.85	0.43	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	7.85	2.80	1.12	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	7.35	2.39	0.85	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	4.92	2.37	0.91	0.73	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	6.62	1.72	0.37	0.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	8.87	3.22	2.01	1.07	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	7.55	4.01	0.94	0.94	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	5.36	1.59	0.60	0.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	9.82	2.57	1.64	1.17	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	8.71	3.11	1.87	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	5.97	2.65	0.66	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	9.40	1.67	1.04	0.21	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	8.61	2.96	1.48	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	6.64	1.70	0.34	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	8.10	3.28	0.77	0.58	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	6.71	3.95	0.69	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	7.54	1.37	1.23	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	8.54	3.94	1.15	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	4.60	0.85	1.70	0.68	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	7.69	1.33	0.74	0.74	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	4.80	0.53	0.53	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	4.15	0.97	0.55	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	8.81	2.62	1.67	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	7.46	1.81	0.20	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	6.22	2.17	1.51	0.47	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	7.69	3.49	0.70	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	7.25	3.02	1.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	5.87	4.41	1.10	0.37	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	6.55	3.64	0.87	0.87	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	10.95	4.26	1.22	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	10.85	1.81	2.71	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	12.21	4.98	0.90	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	7.49	3.29	0.90	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	12.63	6.61	2.01	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	14.73	3.84	1.28	0.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	7.81	1.20	0.60	1.80	0.00
Schwann Cells, donor1	11498-119F4	24.26	7.90	4.70	1.50	1.32
Schwann Cells, donor2	11578-120F3	13.61	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	18.40	4.82	2.63	0.44	0.44
Sebocyte, donor1	11220-116B5	19.17	3.29	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	6.43	2.76	2.76	0.92	0.00
Sebocyte, donor3	11378-118B1	15.46	4.74	2.06	1.24	0.82
Sertoli Cells, donor1	11255-116F4	16.57	26.51	9.94	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	5.65	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	14.16	4.40	2.20	2.20	0.35
Skeletal Muscle Cells, donor2	11358-117H8	15.18	7.23	0.72	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	23.41	9.20	1.67	2.51	2.51
Skeletal Muscle Cells, donor4	11451-119A2	15.08	3.46	2.36	0.94	0.31
Skeletal Muscle Cells, donor5	11455-119A6	13.68	2.68	1.19	1.04	0.59
Skeletal Muscle Cells, donor6	11459-119B1	14.31	7.23	2.62	0.77	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	13.99	4.66	2.65	1.26	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	13.98	3.14	2.14	0.43	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	15.68	4.96	2.78	1.29	1.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	12.30	4.63	2.70	0.76	1.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	31.85	5.79	8.69	2.90	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	24.63	4.95	2.48	1.79	0.41
Skin - palm, donor1	10286-104F7	2.69	0.00	8.06	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	10.09	7.50	2.45	0.00	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	8.18	13.90	2.45	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.13	5.97	2.21	0.00	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	20.57	12.65	3.06	0.83	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	15.47	10.13	2.53	0.28	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	16.70	14.59	1.90	0.85	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	16.49	7.72	1.80	0.52	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	26.23	9.26	7.71	0.31	3.39
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	17.56	24.90	3.56	0.44	1.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	63.49	35.86	7.05	0.00	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	23.43	13.92	2.21	0.44	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	45.28	38.59	5.51	0.00	5.51
Smooth Muscle Cells - Aortic, donor3	11432-118H1	56.40	35.54	12.36	0.77	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	8.01	1.00	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	45.51	42.98	7.32	0.40	7.98
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	21.50	11.75	4.21	0.44	1.77
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	56.72	45.07	15.49	0.13	8.71
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	20.51	5.21	4.23	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	27.76	9.75	2.66	0.59	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	20.79	10.53	3.42	0.43	2.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	30.26	11.22	4.07	0.65	1.30
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.92	2.44	0.61	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	27.53	10.86	4.29	2.02	2.02
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	24.48	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	37.67	28.13	7.15	0.48	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	20.65	8.70	3.39	1.33	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	18.73	7.75	2.80	0.43	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	18.89	8.82	2.52	1.15	1.15
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	44.55	33.72	7.89	0.46	3.87
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	84.07	60.36	19.40	2.16	17.25
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	24.81	15.24	4.48	0.00	2.69
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	30.38	12.63	3.41	1.71	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	13.98	2.28	2.28	0.79	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	19.42	10.27	3.12	0.20	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	28.44	32.31	3.41	0.68	3.19
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	42.27	29.59	9.06	0.60	10.87
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	18.28	6.89	3.18	1.32	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	22.10	13.05	3.33	0.27	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	20.04	8.14	4.01	0.38	3.26
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.02	5.33	2.28	0.51	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	35.28	17.79	3.92	0.15	4.22
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.01	12.75	5.25	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	14.21	6.46	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	36.74	11.16	6.51	0.93	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	32.31	36.86	13.13	0.50	8.08
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	37.92	48.26	7.52	0.00	7.52
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.07	10.62	3.54	0.00	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	19.49	4.08	2.50	0.58	0.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.01	2.34	4.20	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	38.43	35.69	10.36	0.29	8.06
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	40.03	38.50	4.59	0.76	5.10
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	32.15	20.68	3.57	0.94	3.20
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.14	8.11	2.10	0.70	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	26.31	18.01	3.60	0.25	1.68
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	21.43	6.67	1.43	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	51.13	34.50	5.87	0.49	8.32
Smooth Muscle Cells - Uterine, donor1	11258-116F7	29.61	44.19	3.76	0.22	4.42
Smooth Muscle Cells - Uterine, donor3	11466-119B8	25.45	9.36	3.22	1.76	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	10.50	3.11	2.72	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.54	8.99	2.91	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.81	2.60	0.74	0.37	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	20.48	8.26	6.11	0.36	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	26.97	15.90	5.68	0.00	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	14.18	10.24	3.15	0.00	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	12.95	5.59	2.03	0.00	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	17.97	3.99	3.19	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	15.05	6.69	1.25	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	14.21	3.21	1.83	0.00	0.46
Synoviocyte, donor1	11291-117A4	15.82	24.24	3.53	0.00	1.18
Synoviocyte, donor2	11368-117I9	9.55	8.88	3.18	0.84	1.51
Synoviocyte, donor3	11440-118H9	12.51	9.16	2.23	0.67	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	22.51	2.14	2.50	1.43	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	7.93	9.91	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	19.68	4.40	1.85	3.70	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	14.48	4.73	3.87	0.57	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	22.42	3.48	6.19	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	22.91	12.60	4.58	0.00	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	9.47	4.67	3.20	1.60	0.37
Urethra, donor2	10319-105A4	8.99	0.00	7.19	0.00	1.80
Urothelial Cells, donor1	11520-119H8	18.33	5.31	2.66	0.80	0.53
Urothelial Cells, donor2	11600-120H7	14.82	4.41	2.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	14.67	4.35	2.52	0.69	0.23
Urothelial cells, donor0	11216-116B1	13.15	5.80	1.11	0.89	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	2.67	0.00	5.34	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	4.29	0.00	7.15	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	7.53	2.74	2.74	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	4.13	0.34	8.61	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	2.32	1.16	6.39	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	5.21	0.00	9.37	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	3.67	1.84	2.75	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	5.48	0.00	3.65	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	10.86	3.45	1.60	0.37	0.49
Wilms' tumor cell line:HFWT	10597-108E3	3.52	0.88	2.64	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	8.10	2.51	1.12	0.28	0.00
achilles tendon, donor2	10292-104G4	0.00	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	7.90	0.51	6.37	0.25	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	8.36	0.46	3.48	1.16	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	3.44	0.47	6.05	0.83	2.97
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	8.16	0.00	4.90	0.82	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	3.65	0.00	5.06	0.84	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	7.61	1.90	2.54	0.21	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	5.17	0.82	2.99	0.54	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1.76	0.44	2.64	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	5.31	0.00	2.45	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	5.05	0.78	2.33	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	4.05	0.18	2.39	0.00	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	3.49	0.46	1.39	0.23	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	4.40	0.00	3.37	0.52	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	2.63	0.00	2.92	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	4.18	0.46	4.18	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	1.65	0.00	1.65	0.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	4.30	0.00	0.31	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	6.40	0.00	1.71	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	3.34	0.30	2.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	6.26	0.72	1.68	0.24	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	2.67	0.45	2.23	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	4.34	1.33	2.00	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	7.43	0.00	5.57	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	3.01	0.38	4.52	0.75	2.64
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	3.49	0.87	0.87	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	13.89	8.01	1.41	0.47	1.18
adipose tissue, adult, pool1	10010-101C1	9.93	3.41	1.71	0.62	0.16
adipose, donor1	10184-103D4	24.63	2.93	2.35	5.86	0.00
adipose, donor2	10185-103D5	9.73	4.06	2.43	3.24	0.00
adipose, donor3	10186-103D6	10.35	2.45	2.45	1.91	0.27
adipose, donor4	10187-103D7	6.07	3.47	0.87	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	6.47	1.10	2.05	1.26	0.32
adrenal gland, adult, pool1	10081-102A9	7.28	10.91	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	8.40	10.01	4.00	0.80	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	15.72	3.22	1.43	0.36	0.71
amniotic membrane cells, donor1	12235-129G3	23.65	6.96	6.96	0.46	1.85
amniotic membrane cells, donor2	12236-129G4	26.03	4.06	9.80	1.01	0.68
amniotic membrane cells, donor3	12237-129G5	16.50	1.77	12.67	0.59	1.18
amygdala - adult, donor10196	10167-103B5	11.86	1.19	9.49	1.19	1.19
amygdala, adult, donor10252	10151-102I7	18.45	1.01	5.88	1.62	0.20
amygdala, newborn, donor10223	10360-105E9	8.71	2.58	2.58	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	24.70	14.13	6.88	0.89	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	9.49	1.10	5.07	1.76	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	9.02	7.01	1.34	1.34	0.33
aorta, adult, pool1	10052-101G7	19.02	4.90	6.08	0.39	0.20
appendix, adult	10189-103D9	8.93	5.05	3.49	0.78	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	5.50	4.13	1.03	1.03	0.34
artery, adult	10190-103E1	5.43	1.36	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	15.36	3.91	1.59	0.58	0.14
b cell line:RPMI1788	10427-106D4	8.92	3.87	5.95	0.30	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	26.08	24.69	3.88	0.55	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	14.09	6.45	3.57	1.69	0.89
bile duct carcinoma cell line:TFK-1	10496-107C1	3.51	2.34	0.33	0.33	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	3.91	0.00	0.56	0.00	0.56
bladder, adult, pool1	10011-101C2	15.97	4.89	5.76	0.54	0.22
blood, adult, pool1	10053-101G8	13.29	2.21	2.21	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	20.55	8.56	2.57	0.00	0.00
bone marrow, adult	10192-103E3	8.77	4.72	2.70	0.00	0.00
brain, adult, donor1	10084-102B3	14.35	0.00	6.15	2.05	0.00
brain, adult, pool1	10012-101C3	14.37	1.22	8.80	0.78	0.33
brain, fetal, pool1	10085-102B4	21.37	0.00	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	3.63	1.65	2.97	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	34.70	5.12	8.86	2.12	1.50
breast, adult, donor1	10080-102A8	7.58	0.63	0.63	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	7.62	0.89	0.64	0.38	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	14.53	6.18	0.62	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	2.76	2.30	1.38	0.69	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	2.91	0.48	0.48	0.48	0.24
carcinoid cell line:NCI-H1770	10703-109H1	19.75	2.82	7.05	2.35	0.00
carcinoid cell line:NCI-H727	10735-110B6	9.95	4.38	2.19	0.98	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	5.07	0.00	2.22	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	13.31	3.73	1.60	2.40	0.80
caudate nucleus - adult, donor10196	10177-103C6	9.21	0.00	9.21	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	17.57	0.84	11.21	1.34	0.33
caudate nucleus, adult, donor10258	10379-105H1	11.46	0.00	12.23	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	8.06	0.73	9.52	1.10	0.00
cerebellum - adult, donor10196	10173-103C2	5.83	2.91	11.65	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	20.28	1.71	8.11	2.35	0.43
cerebellum, adult, pool1	10083-102B2	15.18	1.38	4.14	4.83	0.00
cerebellum, newborn, donor10223	10357-105E6	4.15	0.00	4.98	3.32	0.83
cerebral meninges, adult	10188-103D8	20.68	3.78	9.83	1.76	0.50
cerebrospinal fluid, donor2	10294-104G6	4.39	0.73	4.39	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	10.21	1.73	9.06	1.01	0.14
cervical cancer cell line:ME-180	10553-107I4	17.23	4.47	0.99	0.83	0.33
cervix, adult, pool1	10013-101C4	19.00	3.36	5.46	0.94	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	19.37	8.22	5.16	0.84	1.39
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	5.23	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	9.07	6.59	1.74	1.62	0.50
choriocarcinoma cell line:SCH	10785-110H2	8.38	2.71	1.11	1.23	1.36
choriocarcinoma cell line:T3M-3	10618-108G6	7.35	4.74	1.42	3.32	1.42
chorionic membrane cells, donor1	12238-129G6	17.38	10.54	4.56	0.57	0.85
chorionic membrane cells, donor2	12239-129G7	38.08	15.51	5.97	0.89	2.98
chorionic membrane cells, donor3	12240-129G8	13.19	6.04	4.40	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	0.00	4.04	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	4.80	0.58	1.73	0.19	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	2.53	0.84	1.48	0.42	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1.28	0.51	1.28	1.03	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	3.14	0.24	0.73	0.00	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	2.44	0.20	2.85	0.61	1.43
chronic myelogenous leukemia cell line:K562	10454-106G4	3.24	1.77	2.06	0.59	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	2.87	0.52	1.30	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.91	13.49	2.29	0.91	0.91
clear cell carcinoma cell line:TEN	10636-108I6	5.90	5.55	1.91	0.00	1.04
colon carcinoma cell line:CACO-2	10513-107D9	17.57	15.74	1.83	0.92	0.92
colon carcinoma cell line:COLO-320	10420-106C6	8.36	1.52	0.76	0.76	0.00
colon, adult, donor1	10082-102B1	15.47	3.57	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	17.16	3.88	4.58	1.88	0.47
colon, fetal, donor1	10070-101I7	12.98	6.18	3.09	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	4.58	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	2.12	33.14	1.70	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	3.02	23.09	1.36	0.00	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	7.05	25.95	1.41	0.28	0.14
corpus callosum, adult, pool1	10042-101F6	17.14	1.77	9.07	4.64	0.44
cruciate ligament, donor2	10295-104G7	5.67	3.24	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	5.62	2.41	1.61	0.80	0.80
diencephalon, adult	10193-103E4	13.44	1.20	10.80	2.16	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	3.44	0.23	5.05	0.46	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	11.03	4.87	2.05	1.28	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	7.22	3.37	0.96	0.72	0.24
ductus deferens, adult	10196-103E7	24.42	0.50	13.95	0.00	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	15.84	4.32	0.00	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	11.77	5.15	3.68	1.47	0.00
dura mater, adult, donor1	10041-101F5	9.33	4.46	3.55	1.07	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	19.54	68.18	3.33	1.78	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	10.75	3.15	1.29	0.86	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	4.32	4.93	1.23	0.62	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	4.84	3.94	0.91	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	5.25	4.32	1.54	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	3.94	5.25	0.00	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	12.07	6.70	3.02	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	15.95	13.05	1.27	0.54	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	10.29	5.31	4.18	0.32	1.61
epidermoid carcinoma cell line:A431	10426-106D3	8.67	3.11	1.22	0.22	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	11.22	3.41	2.20	0.55	0.22
epididymis, adult	10197-103E8	15.70	4.40	7.54	2.09	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	8.52	1.77	1.24	0.35	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	7.47	5.51	1.97	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	11.66	3.15	2.75	0.79	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	11.81	2.46	2.56	0.49	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	15.91	2.24	2.24	0.90	0.67
esophagus, adult, pool1	10015-101C6	11.04	3.72	3.29	0.11	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	9.02	0.88	0.50	1.25	0.00
eye - muscle inferior rectus, donor1	10272-104E2	9.66	0.00	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	6.31	2.10	4.21	2.10	0.00
eye - muscle medial, donor2	10299-104H2	5.95	4.46	4.46	0.00	0.00
eye - muscle superior, donor2	10297-104G9	5.73	4.59	6.88	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	5.83	2.91	1.46	1.46	0.00
eye, fetal, donor1	10054-101G9	12.97	1.53	3.56	1.78	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	6.80	3.85	1.41	0.51	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	8.78	2.61	4.04	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	21.11	0.75	9.10	1.69	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	11.41	3.00	2.40	1.20	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	6.95	8.69	1.74	0.27	0.55
gall bladder, adult	10198-103E9	20.28	4.35	7.24	0.24	1.69
gamma delta positive T cells, donor1	11937-126A2	7.52	0.54	13.96	1.61	0.54
gamma delta positive T cells, donor2	11938-126A3	5.60	0.00	7.10	1.12	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	23.23	6.13	2.53	0.63	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	7.54	1.55	1.74	0.58	0.00
gastric cancer cell line:AZ521	10549-107H9	24.43	6.89	3.28	1.15	1.31
gastric cancer cell line:GSS	10560-108A2	1.83	0.00	1.83	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	8.45	2.06	2.06	1.37	0.46
giant cell carcinoma cell line:LU65	10487-107B1	5.16	1.15	1.38	1.26	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	8.12	3.08	1.40	0.28	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	10.48	5.74	1.50	1.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.66	11.40	2.96	0.42	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	14.75	9.41	3.09	0.28	0.84
glioblastoma cell line:T98G	10485-107A8	10.04	2.21	2.10	0.22	0.33
glioma cell line:GI-1	10413-106B8	6.15	2.34	2.64	0.59	1.17
globus pallidus - adult, donor10196	10175-103C4	10.20	0.73	9.48	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	22.70	0.98	5.37	2.20	0.24
globus pallidus, adult, donor10258	10367-105F7	9.58	4.11	1.37	6.85	0.00
globus pallidus, newborn, donor10223	10364-105F4	3.20	3.73	6.93	2.66	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	7.34	0.00	12.24	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	10.45	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	14.72	13.76	1.60	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	11.02	4.13	2.75	1.38	0.00
hIPS +CCl2, biol_rep2	14384-156C1	6.40	2.74	3.66	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	7.09	2.58	1.29	0.00	0.00
hIPS, biol_rep1	14380-156B6	1.44	1.44	4.31	4.31	1.44
hIPS, biol_rep2	14381-156B7	4.80	2.06	1.37	2.06	0.00
hIPS, biol_rep3	14382-156B8	5.52	0.00	12.14	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	5.46	2.87	2.87	0.00	0.00
heart - mitral valve, adult	10205-103F7	9.27	3.59	2.09	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	11.50	2.09	6.54	1.31	0.00
heart - tricuspid valve, adult	10207-103F9	8.33	7.49	3.33	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	11.63	2.45	2.65	0.61	0.61
heart, adult, diseased, donor1	10051-101G6	17.03	3.41	3.83	1.70	0.00
heart, adult, pool1	10016-101C7	14.03	2.30	3.91	0.69	0.23
heart, fetal, pool1	10046-101G1	11.81	2.26	1.85	1.85	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	16.04	12.96	1.85	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	1.19	1.19	0.00	3.57	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	9.83	3.76	0.99	1.44	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	12.99	4.13	1.94	0.49	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	9.70	3.74	1.82	1.21	0.40
hepatoma cell line:Li-7	10484-107A7	19.02	9.79	1.00	1.11	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	4.72	2.11	1.81	0.10	0.30
hippocampus - adult, donor10196	10169-103B7	10.41	0.00	0.95	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	18.98	0.82	7.55	1.84	0.00
hippocampus, adult, donor10258	10374-105G5	10.46	1.00	14.44	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	5.64	1.41	4.58	1.06	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	8.54	3.05	1.22	1.83	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	7.66	2.36	0.59	1.18	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	6.60	3.05	1.27	1.52	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	12.41	1.69	0.56	3.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	9.30	1.29	2.58	4.65	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	11.39	3.42	3.04	6.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	12.26	3.80	2.34	3.21	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	12.06	4.09	3.88	3.02	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	9.18	4.59	2.92	2.50	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	18.23	7.10	3.32	3.32	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	12.05	6.91	2.57	3.70	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	17.51	6.06	6.73	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	7.67	3.91	0.78	1.25	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	7.86	3.44	0.49	0.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.11	4.36	1.75	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	10.50	2.67	2.10	5.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	9.16	2.62	2.18	1.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	13.49	5.50	2.50	4.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	12.43	2.45	3.58	1.70	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	11.82	2.73	2.73	2.73	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	12.53	3.76	5.33	2.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	10.61	5.72	3.92	2.94	1.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	11.90	6.39	3.48	3.19	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	12.55	4.78	3.59	2.99	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	7.57	3.33	1.66	2.03	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	6.85	2.28	0.00	2.28	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	15.92	4.90	1.63	2.45	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	13.38	6.34	1.41	2.11	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	12.67	1.90	2.53	1.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	12.71	6.36	1.82	3.03	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.41	4.14	2.07	2.59	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	9.96	0.00	0.66	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	5.90	4.10	1.80	2.31	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	13.29	8.18	2.30	3.07	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	9.84	4.54	1.51	2.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	6.72	9.75	2.02	1.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	9.18	2.42	2.42	1.21	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	10.70	4.90	2.23	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	10.24	2.93	2.93	3.41	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	12.84	3.67	1.53	3.67	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	19.52	6.51	9.76	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	14.23	3.31	1.99	1.65	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	9.85	2.19	2.74	4.38	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	9.41	3.98	4.34	2.90	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	12.46	4.27	3.20	1.42	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	10.74	2.39	2.39	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	16.79	5.69	2.98	3.79	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.43	4.85	1.89	1.89	0.81
immature langerhans cells, donor1	11904-125F5	6.54	43.59	2.18	0.24	0.24
immature langerhans cells, donor2	11905-125F6	3.17	30.89	2.38	1.58	0.00
insula, adult, pool1	10039-101F3	21.67	0.95	10.32	2.18	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	17.88	0.98	1.63	0.00	0.00
kidney, adult, pool1	10017-101C8	17.22	5.61	4.01	1.20	1.20
kidney, fetal, pool1	10045-101F9	12.80	3.68	4.46	2.19	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	10.79	7.10	1.28	0.71	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	8.43	5.67	2.49	1.11	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	11.38	7.16	4.04	1.10	0.73
left atrium, adult, donor1	10079-102A7	5.99	1.63	1.63	0.00	0.00
left ventricle, adult, donor1	10078-102A6	6.57	1.52	1.52	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	8.48	6.02	0.82	0.82	1.37
leiomyoma cell line:10964C	10569-108B2	44.19	27.30	10.06	0.36	2.87
leiomyoma cell line:15242A	10570-108B3	35.87	55.98	11.41	0.00	7.07
leiomyoma cell line:15425	10571-108B4	35.45	25.25	8.50	0.00	3.40
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	11.50	8.36	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	5.90	2.95	1.65	0.24	0.94
liposarcoma cell line:KMLS-1	10782-110G8	9.06	6.40	0.47	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	13.89	6.09	2.19	2.31	0.49
liver, adult, pool1	10018-101C9	25.44	13.13	4.21	0.49	0.65
liver, fetal, pool1	10086-102B5	2.82	1.88	1.88	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	8.60	0.87	7.15	1.75	0.87
locus coeruleus, adult, donor10252	10165-103B3	19.19	1.29	7.01	2.58	0.00
locus coeruleus, adult, donor10258	10375-105G6	13.54	2.54	8.75	2.54	0.00
locus coeruleus, newborn, donor10223	10362-105F2	9.25	4.21	5.05	1.68	0.42
lung adenocarcinoma cell line:A549	10499-107C4	15.78	6.50	5.40	0.69	1.11
lung adenocarcinoma cell line:PC-14	10408-106B3	10.34	1.38	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	17.80	8.57	2.11	0.79	0.00
lung, adult, pool1	10019-101D1	10.16	5.08	3.78	0.71	0.24
lung, fetal, donor1	10068-101I5	13.98	11.13	7.14	1.43	0.29
lung, right lower lobe, adult, donor1	10075-102A3	9.62	1.83	3.67	0.46	0.46
lymph node, adult, donor1	10077-102A5	7.10	3.31	5.21	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	11.40	7.01	6.36	0.22	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	4.08	0.30	1.96	0.00	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	2.55	3.40	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	29.30	11.10	7.99	0.00	0.44
mature adipocyte, donor2	12232-129F9	18.89	14.11	7.68	0.62	0.62
mature adipocyte, donor3	12233-129G1	14.93	11.14	4.98	0.95	0.24
mature adipocyte, donor4	12234-129G2	16.32	8.95	4.47	1.05	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	7.62	2.86	2.38	1.19	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	16.92	0.00	12.41	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	15.45	0.37	7.72	0.92	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	13.98	0.64	6.67	0.64	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	10.24	4.69	5.54	0.00	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	17.55	0.68	7.43	1.18	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	17.19	0.85	6.79	1.91	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	0.00	9.63	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	9.69	1.44	7.90	3.23	0.00
medulla oblongata - adult, donor10196	10174-103C3	7.79	2.60	5.19	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	17.65	0.62	5.11	1.39	0.62
medulla oblongata, adult, pool1	10038-101F2	13.80	1.71	7.43	1.96	0.49
medulla oblongata, newborn, donor10223	10361-105F1	6.60	2.43	7.29	1.39	0.69
medulloblastoma cell line:D283 Med	10838-111E1	5.54	1.11	1.11	1.77	0.44
medulloblastoma cell line:ONS-76	10759-110E3	9.90	3.91	1.59	1.59	0.12
melanoma cell line:COLO 679	10514-107E1	8.19	4.60	0.72	0.29	0.29
melanoma cell line:G-361	10465-106H6	4.61	0.27	0.27	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	16.46	7.78	1.99	0.36	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	6.17	1.76	0.88	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	10.11	0.78	2.85	2.59	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	29.31	9.51	3.53	0.92	1.53
mesenchymal precursor cell - adipose, donor2	11748-123G2	20.54	9.45	3.27	0.55	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	20.29	6.63	2.07	0.41	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	22.62	8.29	3.23	0.70	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.80	7.13	2.70	0.96	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	8.33	10.41	1.39	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	28.32	12.53	4.98	0.17	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	18.40	6.21	2.76	1.04	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.68	7.16	4.51	0.66	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	27.01	10.26	3.65	0.27	1.49
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	30.02	21.05	4.41	0.28	3.98
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	13.50	10.21	1.32	0.33	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	23.25	18.96	3.87	0.42	2.08
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	28.28	13.61	2.79	0.70	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	27.77	13.07	2.65	0.41	2.04
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.74	20.85	4.31	0.72	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.52	8.48	2.79	0.72	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	18.24	15.05	4.56	0.46	3.65
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	29.37	24.75	8.39	0.84	6.29
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	24.81	16.14	3.14	0.45	1.20
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.22	12.52	4.11	0.44	2.36
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	16.57	9.94	2.95	1.10	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	16.88	18.03	1.72	0.29	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	20.21	8.84	5.05	0.00	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.98	10.05	5.94	1.83	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	13.30	8.95	3.84	0.77	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	16.49	8.38	4.19	0.26	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	13.25	7.70	4.31	0.31	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	12.47	7.06	3.53	0.00	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	16.92	8.80	4.06	1.02	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	13.36	4.32	3.54	1.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	10.19	6.02	4.17	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	22.78	7.50	3.75	1.44	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	16.51	6.25	4.46	0.67	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	16.82	7.93	5.29	0.00	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	17.60	7.33	3.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	17.12	5.71	3.69	1.01	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	15.97	5.32	3.68	1.64	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	12.46	7.73	2.58	0.86	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	21.88	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	15.91	9.09	2.60	0.32	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	8.73	7.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.99	6.93	4.26	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	14.72	4.09	5.72	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	16.71	9.72	3.50	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	8.39	6.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	13.91	7.95	3.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	14.30	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	15.42	12.45	5.93	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	20.71	9.75	2.44	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	13.30	6.33	6.33	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	9.66	3.10	2.76	0.00	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	0.00	3.44	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	14.67	4.48	1.63	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.09	3.18	1.59	0.00	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	13.56	2.95	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.17	3.12	1.25	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	6.68	4.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	5.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	8.26	2.75	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	14.35	0.00	1.98	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	12.34	0.00	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	11.45	1.91	2.54	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	16.52	4.84	2.82	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	2.18	8.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	16.47	3.80	7.60	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	13.96	2.43	3.64	1.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	4.52	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.83	4.12	6.59	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	12.10	4.96	3.17	0.40	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	12.98	3.89	1.30	0.65	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	5.09	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	26.31	12.38	0.77	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	16.77	16.30	3.07	1.42	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	16.45	15.29	2.09	0.70	3.01
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	8.55	8.55	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	11.20	11.30	1.75	0.21	0.51
mesothelioma cell line:Mero-25	10850-111F4	10.67	11.57	2.04	0.45	1.36
mesothelioma cell line:Mero-41	10851-111F5	9.05	12.22	3.67	0.98	0.98
mesothelioma cell line:Mero-48a	10852-111F6	26.35	38.09	9.30	0.66	4.65
mesothelioma cell line:Mero-82	10853-111F7	15.24	14.19	1.31	0.53	0.79
mesothelioma cell line:Mero-83	10854-111F8	10.38	9.02	3.40	0.17	2.38
mesothelioma cell line:Mero-84	10855-111F9	6.57	5.81	3.79	0.25	1.77
mesothelioma cell line:Mero-95	10856-111G1	7.45	8.07	2.07	0.62	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	11.60	7.45	2.48	0.99	1.49
mesothelioma cell line:NCI-H226	10846-111E9	5.79	9.05	3.80	0.18	2.35
mesothelioma cell line:NCI-H2452	10848-111F2	8.71	7.52	1.71	0.34	0.17
mesothelioma cell line:NCI-H28	10845-111E8	8.91	2.80	2.29	0.51	0.51
mesothelioma cell line:No36	10857-111G2	7.83	7.50	3.59	0.65	0.65
mesothelioma cell line:ONE58	10858-111G3	5.42	7.86	1.08	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	5.18	10.56	1.54	0.19	0.38
migratory langerhans cells, donor2	11902-125F3	6.35	14.90	2.81	0.24	0.24
migratory langerhans cells, donor3	11903-125F4	4.49	11.85	4.85	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.67	4.90	1.63	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	16.53	7.63	1.48	0.42	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	15.66	10.14	3.23	0.69	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	5.33	14.27	0.76	0.57	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	6.28	0.18	2.22	0.18	0.18
myeloma cell line:PCM6	10474-106I6	4.94	1.78	2.37	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	8.62	3.55	1.52	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	8.83	3.92	1.18	0.59	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	20.28	1.67	3.57	1.00	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	19.12	2.72	3.75	0.88	0.74
nasal epithelial cells, donor2	12227-129F4	14.35	4.97	2.21	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	9.20	1.38	2.53	5.75	0.69
neuroblastoma cell line:NB-1	10539-107G8	11.97	3.93	3.37	3.18	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	13.71	1.90	3.59	2.53	0.42
neuroblastoma cell line:NH-12	10555-107I6	9.69	0.93	5.03	3.54	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	4.27	0.00	2.85	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	7.92	1.11	2.22	0.48	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	7.65	0.20	2.01	1.21	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	3.81	0.00	2.54	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	17.57	11.71	1.86	0.80	1.60
neutrophil PMN, donor1	12133-128D9	0.00	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	5.41	0.17	4.90	0.51	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	11.21	2.40	2.40	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	27.89	16.67	3.53	1.28	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	22.33	15.50	3.94	1.05	3.15
nucleus accumbens, adult, pool1	10037-101F1	17.25	1.22	10.41	1.97	0.00
occipital cortex - adult, donor10196	10172-103C1	14.42	0.00	10.30	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	10.20	2.15	6.17	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	10.92	1.46	6.55	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	22.04	1.05	9.71	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	20.17	0.00	6.44	2.57	0.00
occipital pole, adult, pool1	10036-101E9	20.03	0.95	8.83	2.29	0.16
olfactory region, adult	10195-103E6	9.74	1.15	11.08	1.15	0.57
optic nerve, donor1	10277-104E7	6.00	2.00	10.01	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	9.11	2.16	1.59	0.68	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	7.01	0.82	0.69	0.27	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	10.67	1.86	1.35	0.51	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	9.36	3.47	1.85	0.69	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	12.93	6.76	3.23	0.29	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	11.21	5.61	3.74	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	6.36	1.27	0.42	0.85	0.85
ovary, adult, pool1	10020-101D2	14.50	3.32	5.24	1.14	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	5.32	3.85	2.02	0.37	0.92
pancreas, adult, donor1	10049-101G4	23.52	3.76	2.82	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	4.47	3.91	0.28	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	14.48	8.18	3.58	1.36	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	13.08	15.40	1.16	1.99	0.66
paracentral gyrus, adult, pool1	10035-101E8	18.95	1.65	10.34	1.28	0.09
parietal cortex, adult, donor10258	10373-105G4	11.01	1.47	10.28	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	11.29	0.00	4.70	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	10.55	1.14	4.56	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	19.21	1.06	9.08	2.03	0.35
parietal lobe, fetal, donor1	10072-101I9	11.64	0.00	2.91	3.88	0.00
parietal lobe, newborn, donor10223	10356-105E5	8.97	3.36	5.23	0.37	0.37
parotid gland, adult	10199-103F1	25.28	6.17	19.12	0.62	2.47
penis, adult	10200-103F2	5.91	1.61	4.83	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	4.28	0.00	1.86	2.05	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	8.45	2.33	1.75	0.44	0.15
pineal gland - adult, donor10196	10179-103C8	15.48	2.58	5.81	1.94	0.00
pineal gland, adult, donor10252	10160-103A7	14.21	1.18	7.11	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	13.17	1.25	10.66	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	25.30	4.05	7.08	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	26.06	4.17	4.69	1.56	0.52
pituitary gland, adult, donor10258	10378-105G9	13.62	2.55	4.26	3.40	0.00
placenta, adult, pool1	10021-101D3	12.47	5.27	5.16	0.75	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	8.21	5.03	6.62	0.40	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	15.56	7.47	3.74	0.93	0.47
pons, adult, pool1	10033-101E6	11.88	1.38	8.86	1.89	0.69
postcentral gyrus, adult, pool1	10032-101E5	18.92	0.87	10.98	1.74	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	0.00	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	15.29	10.34	2.91	1.75	0.44
prostate cancer cell line:PC-3	10439-106E7	8.17	5.45	2.90	1.09	3.45
prostate, adult, pool1	10022-101D4	18.32	3.36	5.71	1.18	0.63
putamen, adult, donor10196	10176-103C5	25.73	0.94	19.83	1.42	0.24
putamen, adult, donor10252	10152-102I8	17.65	1.96	19.61	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	7.65	2.19	5.46	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	12.32	0.72	16.43	1.21	0.00
putamen, newborn, donor10223	10365-105F5	3.00	3.00	4.50	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	10.18	11.64	1.45	0.29	3.78
rectum, fetal, donor1	10067-101I4	6.95	2.78	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	11.45	9.12	2.97	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	2.90	33.55	0.83	0.00	0.41
retina, adult, pool1	10030-101E3	16.10	1.69	7.95	3.68	0.40
retinoblastoma cell line:Y79	10475-106I7	4.94	0.52	0.52	2.34	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	13.16	3.32	0.98	0.74	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	7.03	0.00	0.56	1.69	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	12.88	6.82	0.00	0.76	0.76
salivary acinar cells, donor1	11771-123I7	7.93	4.53	1.46	0.32	0.00
salivary acinar cells, donor2	11772-123I8	7.30	2.20	1.24	0.69	0.41
salivary acinar cells, donor3	11773-123I9	7.94	1.99	0.00	1.32	0.66
salivary gland, adult, pool1	10093-102C3	22.88	10.87	13.15	2.86	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	9.78	3.04	1.52	0.25	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	9.05	3.53	1.18	0.82	0.12
seminal vesicle, adult	10201-103F3	23.28	9.52	13.76	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	16.28	14.82	0.97	0.49	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	25.41	15.85	5.79	1.01	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	19.07	23.08	8.03	1.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	6.18	1.07	1.75	1.34	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	24.43	9.84	4.20	0.88	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	21.68	12.64	3.48	0.52	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	4.26	0.71	4.26	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	9.00	2.28	2.04	0.72	0.36
skeletal muscle, fetal, donor1	10066-101I3	11.06	1.01	1.01	4.02	0.00
skin, adult, donor1	10074-102A2	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	11.36	1.26	6.31	2.52	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	19.01	6.00	1.67	2.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	8.20	2.52	3.15	2.84	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	6.75	0.58	2.12	0.96	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	10.55	1.15	0.66	0.33	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	8.20	5.79	1.29	4.50	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	15.47	16.78	3.49	0.65	1.96
small intestine, adult, pool1	10024-101D6	13.62	5.61	3.34	1.79	0.24
small intestine, fetal, donor1	10064-101I1	8.35	1.47	1.23	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	13.34	11.80	3.59	1.03	1.54
smooth muscle, adult, pool1	10048-101G3	18.09	4.14	4.39	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	17.69	4.82	1.34	0.80	0.27
spinal cord - adult, donor10196	10181-103D1	6.88	1.15	5.28	1.61	0.23
spinal cord, adult, donor10252	10159-103A6	13.01	2.76	3.55	1.18	0.00
spinal cord, adult, donor10258	10369-105F9	7.61	2.77	13.14	2.77	0.00
spinal cord, fetal, donor1	10056-101H2	24.39	3.66	6.71	7.93	1.83
spinal cord, newborn, donor10223	10359-105E8	13.32	2.30	9.18	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	19.57	14.19	2.24	0.75	1.34
spleen, adult, pool1	10025-101D7	7.49	3.08	2.64	0.77	0.55
spleen, fetal, pool1	10044-101F8	7.63	6.20	3.26	0.95	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	2.79	1.66	2.90	0.41	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	12.72	15.38	1.90	1.14	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	11.53	4.19	2.45	1.40	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	15.25	13.29	1.56	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	24.54	10.69	4.28	1.46	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	18.64	6.35	2.54	3.81	2.12
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	11.42	10.58	1.69	0.00	0.00
stomach, fetal, donor1	10062-101H8	13.88	6.41	4.27	2.14	0.00
submaxillary gland, adult	10202-103F4	18.23	8.55	11.39	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	18.28	2.08	5.61	2.70	0.21
substantia nigra, adult, donor10258	10371-105G2	6.72	2.59	11.90	3.10	0.00
substantia nigra, newborn, donor10223	10358-105E7	4.24	0.71	3.53	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	7.80	1.15	0.92	1.15	0.46
temporal lobe, adult, pool1	10031-101E4	25.43	1.36	11.95	1.78	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	24.22	0.71	7.12	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	20.22	2.20	8.79	3.52	1.32
tenocyte, donor1	11763-123H8	16.41	8.38	5.59	0.70	1.75
tenocyte, donor2	11765-123I1	10.68	5.34	4.20	1.53	0.38
tenocyte, donor3	11768-123I4	12.60	7.41	2.97	0.37	2.59
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	9.18	2.21	0.85	1.70	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	15.41	3.55	1.23	1.23	0.15
teratocarcinoma cell line:PA-1	10807-111A6	4.49	0.46	0.46	3.72	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	8.38	1.78	0.63	2.54	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	6.81	1.89	0.76	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	7.74	2.07	1.09	2.18	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	7.49	2.28	0.65	1.30	0.33
testis, adult, pool1	10026-101D8	12.35	2.58	6.87	3.11	0.64
testis, adult, pool2	10096-102C6	9.47	3.16	13.98	4.96	0.00
thalamus - adult, donor10196	10168-103B6	11.04	0.00	7.73	2.21	0.00
thalamus, adult, donor10252	10154-103A1	14.22	1.41	7.19	2.19	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	6.16	1.54	16.94	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.39	0.82	4.61	1.32	0.00
thalamus, newborn, donor10223	10366-105F6	2.88	0.58	4.03	1.15	2.88
throat, adult	10209-103G2	10.99	2.25	4.99	2.00	0.00
throat, fetal, donor1	10061-101H7	12.19	0.61	4.27	2.13	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	7.35	0.99	1.99	0.40	0.00
thymus, adult, pool1	10027-101D9	5.77	1.29	4.57	1.39	0.20
thymus, fetal, pool1	10043-101F7	9.25	1.66	4.36	0.73	0.83
thyroid carcinoma cell line:KHM-5M	10776-110G2	7.31	7.45	1.46	1.06	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	17.88	4.47	3.21	0.84	0.42
thyroid, adult, pool1	10028-101E1	21.46	2.99	10.45	1.77	0.37
thyroid, fetal, donor1	10060-101H6	11.07	1.05	2.90	1.32	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	7.44	0.93	1.86	0.47	0.47
tongue, fetal, donor1	10059-101H5	9.06	2.76	3.15	2.36	0.00
tonsil, adult, pool1	10047-101G2	12.42	3.91	6.81	1.00	0.20
trachea, adult, pool1	10029-101E2	14.23	7.03	4.25	1.23	0.49
trachea, fetal, donor1	10058-101H4	15.00	3.85	3.08	1.15	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	27.28	20.19	2.83	1.06	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	16.01	6.99	2.23	0.81	0.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	5.48	3.60	1.41	0.78	0.31
tridermal teratoma cell line:HGRT	10694-109G1	19.03	11.42	1.90	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	14.22	4.23	1.44	0.76	0.17
umbilical cord, fetal, donor1	10057-101H3	12.52	0.00	2.09	0.00	4.17
uterus, adult, pool1	10100-102D1	16.21	8.02	6.14	1.19	0.51
uterus, fetal, donor1	10055-101H1	15.36	5.63	1.54	0.51	0.00
vagina, adult	10204-103F6	11.63	1.94	6.46	0.00	0.65
vein, adult	10191-103E2	7.89	2.85	5.26	0.66	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	5.61	2.94	3.20	0.80	1.07